Updated Phase 1 Results Of A First-In-Human Open-Label Study Of Lcar-B38m, A Structurally Differentiated Chimeric Antigen Receptor T (Car- T) Cell Therapy Targeting B-Cell Maturation Antigen (Bcma)Lijuan Chen,Jie Xu,Weijun Fu,Shiwei Jin,Shuangshuang Yang,Sun Yan,Wen Wu,Yuanfang Liu,Wu Zhang,Xiangqin Weng,Yan Wang,Jin Wang,Xiaoyi Ding,Biao Li,Jiang Zhu,Zhu Chen,Frank Xiao-Hu Fan,Jianyong Li,Jian Hou,Sai-Juan Chen,Jian-Qing MiBLOOD(2019)引用 22|浏览45暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络